Identification and validation of platinum resistance signature in gastric cancer
The 21 gene-signature for platinum was developed to predict response to platinum chemotherapy for GC patients. It is worthwhile to further evaluate the molecular biology and the clinical applications of this signature.
Authors
- Zhongyin Yang (ORCID: https://orcid.org/0000-0003-3595-9417)
- Beiqin Yu (ORCID: https://orcid.org/0000-0003-1043-0445)
- Nan Zhu (ORCID: https://orcid.org/0000-0003-4710-4571)
- Qingqing Sang
- Bingya Liu (ORCID: https://orcid.org/0000-0002-4406-3762)
- Jianfang Li (ORCID: https://orcid.org/0000-0003-3789-5680)
- Wenjing Yan (ORCID: https://orcid.org/0000-0001-7115-4486)
- Yupeng Zhao (ORCID: https://orcid.org/0000-0001-7999-8018)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Zhongda Hospital Southeast University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1186/s12935-025-03777-z
- Citations
- 1
- Primary Topic
- Trace Elements in Health
- Type
- article
- Field-Weighted Citation Impact
- 1.12
Funders
- National Natural Science Foundation of China